Session 9: Cancer Precision Medicine

This course will give an overview of Cancer Precision Medicine and Precision Therapeutics in healthcare today.

Target Audience

  • Physicians
  • Nurse Practitioners
  • Physician Assistants
  • Pharmacists
  • Genetic Counselors
  • Other clinicians

Learning Objectives

Participants who engage in this education intervention will be able to:

  • Indicate cancer therapy targets in the somatic and germline genome.
  • Identify the differential functional and therapeutic significance of genomic alterations in a context dependent fashion.
  • Summarize the relevance of spatiotemporal heterogeneity and clonal evolution as it pertains to targeted therapy in cancer. 
Additional information
AttachmentSize
File Cancer Precision Medicine CME 8-15-2023.pptx6.47 MB
PDF icon NCI Match Trial.pdf1.46 MB
PDF icon Liquid biopsy to capture tumor evolution.pdf1.88 MB

Contact

Name: 
Kellie LeGrave
Phone Number: 
+1 (414) 955-4139
Email: 
klegrave@mcw.edu
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.50 Genetic Counselor CEU
  • 1.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
03/14/2024
Course expires: 
07/12/2024
Cost:
$0.00
Part of: 
Precision Medicine Continuing Education Program Spring 2024

This module is presented with a pre-recorded PowerPoint presentation and sound.  An audio lecture is given using visual key points listed on the PowerPoint presentation.  Following the presentation, learners will be asked quiz questions to test retainment of knowledge gained in the presentation. Learners are able to complete the module at their own pace.

Ben George, MD is an Associate Professor of Medicine and the William F. Stapp Endowed Chair in the Division of Hematology and Oncology at the Medical College of Wisconsin, Milwaukee, WI. Dr. George is a GI medical oncologist with a research and clinical focus on Pancreatic Ductal Adenocarcinoma. He is the Associate Director of Cancer Genomics and Precision Medicine at the Genomic Sciences and Precision Medicine Center at the Medical College of Wisconsin and serves as the Director of the Phase 1 Clinical Trials program. 
 
Activity Director
John Meurer, MD, MBA
 
Planning Committee:
John Meurer, MD, MBA
Institute Director, Professor
Administration, Institute for Health & Equity

 

Bradley Stockard, PharmD
Assistant Professor
Administration, School of Pharmacy Administration

 

Jennifer Geurts, MS, CGC
Director, Assistant Professor
Administration, Institute for Health and Equity

 

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

 

  • Bradley Stockard
  • Donald Basel
  • Gwen Lomberk
  • Jake Luo
  • Jennifer Geurts
  • Jeremy Garrett
  • John Meurer
  • Michael Zimmerman

The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.

 

Name
Company
Role
Honey Reddi, PhD
Belay Diagnostics
Biofidelity, Inc.
Employee
Consultant
Ben George, MD
Ipsen, Foundation Medicine,
Taiho Oncology
Consultant

 

Available Credit

  • 1.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.50 Genetic Counselor CEU
  • 1.50 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$0.00
Please login or register to take this course.